Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition-Reference-Cited by-同舟云学术

Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Lione Lucia¹²,Salvatori Erika³,Petrazzuolo Adriana¹⁴⁵⁶,Massacci Alice¹,Maggio Roberta¹,Conforti Antonella³,Compagnone Mirco⁷,Aurisicchio Luigi¹³⁶⁸⁷,Ciliberto Gennaro⁹,Palombo Fabio¹⁷^ORCID

Affiliation:

1. Cancer Immunology, Takis, Rome, Italy

2. Università Magna Grecia, Catanzaro, Italy

3. Evvivax, Rome, Italy

4. Equipe Labellisée Par La Ligue Contre Le Cancer, Université De Paris, Sorbonne Université, INSERM U1138, Centre De Recherche Des Cordeliers, Paris, France

5. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France

6. Biogem, Ariano Irpino, Italy

7. Cancer immunology, Neomatrix, Rome, Italy

8. Université Paris Saclay, Faculty of Medicine Kremlin Bicêtre, France

9. Scientific Directorate, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1898832

Reference43 articles.